GlassScriptPhysician profile
Thao Duong
NPI 1205272945
$26,502.70
in general payments reported to CMS, 2019-2025
32 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,203 · 2020: $12K · 2021: $6,293 · 2022: $1,001 · 2023: $2,176 · 2024: $1,124 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,929.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $7,500.00 | 2020 | |
| Boston Scientific Corporation | $6,011.85 | 2021-2025 | Watchman Flx, Avvigo Guidance System, Guidezilla |
| Abbott Laboratories | $5,454.98 | 2019-2023 | Optis, Amplatzer Amulet, Amplatzer Piccolo |
| Biotronik INC. | $2,568.96 | 2019-2022 | |
| Shockwave Medical, INC | $841.49 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $679.06 | 2019-2025 | Lifevest |
| Medtronic, INC. | $615.23 | 2021-2024 | Linq II, Corevalve Evolut R, Resolute Onyx |
| Medical Device Business Services, INC. | $375.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $354.07 | 2019-2025 | |
| Abiomed | $311.08 | 2019-2022 | |
| Irhythm Technologies, INC. | $304.39 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $217.21 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $181.42 | 2020-2025 | |
| Penumbra, INC. | $178.69 | 2023-2024 | Indigo System |
| Cardiovascular Systems INC. | $127.05 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $120.77 | 2023 | |
| Novo Nordisk INC | $85.50 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $82.85 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $71.66 | 2024-2025 | Amvuttra |
| Terumo Medical Corporation | $63.47 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $52.34 | 2022-2024 | Xarelto |
| Vital Connect, INC | $47.01 | 2025 | Vitalpatch Rtm |
| Biobeat USA INC. | $44.73 | 2024 | Bb-613 Bpm Kit |
| Philips North America LLC | $37.35 | 2025 | Ecc Solutions |
| Kiniksa Pharmaceuticals, LTD. | $30.98 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $25.23 | 2024 | Wainua |
| Teleflex LLC | $24.70 | 2021 | |
| Endotronix, INC. | $23.02 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Regeneron Healthcare Solutions, INC. | $22.76 | 2025 | Evkeeza |
| Cardiva Medical, INC. | $20.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.93 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $13.14 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.